- Home
- HALO vs HSIC Comparison
HALO vs HSIC Comparison
Compare HALO & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- HSIC
- Stock Information
- Founded
- HALO 1998
- HSIC 1932
- Country
- HALO United States
- HSIC United States
- Employees
- HALO N/A
- HSIC N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- HSIC Medical Specialities
- Sector
- HALO Health Care
- HSIC Health Care
- Exchange
- HALO Nasdaq
- HSIC Nasdaq
- Market Cap
- HALO 7.4B
- HSIC 8.1B
- IPO Year
- HALO N/A
- HSIC 1995
- Fundamental
- Price
- HALO $65.87
- HSIC $68.64
- Analyst Decision
- HALO Buy
- HSIC Buy
- Analyst Count
- HALO 9
- HSIC 10
- Target Price
- HALO $63.78
- HSIC $79.30
- AVG Volume (30 Days)
- HALO 2.0M
- HSIC 1.4M
- Earning Date
- HALO 05-06-2025
- HSIC 05-05-2025
- Dividend Yield
- HALO N/A
- HSIC N/A
- EPS Growth
- HALO 55.40
- HSIC 8.11
- EPS
- HALO 3.76
- HSIC 3.21
- Revenue
- HALO $1,084,306,000.00
- HSIC $12,669,000,000.00
- Revenue This Year
- HALO $20.06
- HSIC $4.73
- Revenue Next Year
- HALO $24.20
- HSIC $3.62
- P/E Ratio
- HALO $17.52
- HSIC $21.39
- Revenue Growth
- HALO 25.64
- HSIC 1.75
- 52 Week Low
- HALO $41.28
- HSIC $60.56
- 52 Week High
- HALO $70.51
- HSIC $82.49
- Technical
- Relative Strength Index (RSI)
- HALO 58.99
- HSIC 57.50
- Support Level
- HALO $58.38
- HSIC $65.86
- Resistance Level
- HALO $70.51
- HSIC $69.38
- Average True Range (ATR)
- HALO 2.50
- HSIC 1.90
- MACD
- HALO 0.88
- HSIC 0.65
- Stochastic Oscillator
- HALO 64.61
- HSIC 89.09
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.